Full-Time

Associate Territory Manager

Bone Growth Therapies

Posted on 9/16/2025

Orthofix

Orthofix

1,001-5,000 employees

Develops spine and orthopedic reconstructive devices

Compensation Overview

$60k - $65k/yr

+ Commissions based on performance

Jackson Township, NJ, USA + 1 more

More locations: New York, NY, USA

In Person

Territory includes NYC and Northern NJ; travel required within territory by plane, car, etc. about 90%.

Category
Sales & Account Management (1)
Required Skills
Sales
Requirements
  • At least 1 year sales experience (business to business) with documented success.
  • An above average level of intelligence with a bachelor's degree preferred.
  • An ability to articulate effectively showing poise, depth of thought and good judgment and decision making.
  • An ability to present to individuals or larger groups.
  • An exceptional level of technical competence with regard to product knowledge and surgical procedures.
  • An ability to effectively manage activities and development of a Sales Representative.
Responsibilities
  • To assist Territory Managers in achieving sales results at or above established quotas for total and individual product segments.
  • To provide direct, personal and timely service, via a consultative approach, to physicians, podiatrists, patients, managed care or other payors, representing Orthofix in a professional and straight forward manner.
  • Additional responsibilities will include managing, directing, and assisting any authorized Orthofix distributor.
  • Supporting Territory Managers, accounts and patients within your geography.
  • Assist with patient fittings including conducting educational meetings with patients and office staff regarding the benefits of the Orthofix stimulation products, discussing explanation of benefits and patient responsibilities, facilitating paperwork collections for order submissions, and fielding patient phone calls.
  • Collect and submit HIPPA covered information related to orders.
  • Regular attendance required.
Desired Qualifications
  • Medical Device Sales.

Orthofix Medical Inc. focuses on reconstructive and regenerative orthopedic and spine solutions for surgeons and hospitals. It operates in two groups: Global Spine, which offers spinal fusion products such as bone growth stimulators, spinal implants, and biologics, and Global Orthopedics, which provides devices for fracture fixation, deformity correction, and bone reconstruction. The company’s products are used to treat musculoskeletal conditions like degenerative disc disease, spinal stenosis, and fractures, and are sold through a direct sales force and a network of independent distributors in the U.S. and internationally. Orthofix grows by developing and commercializing new products and by acquiring complementary technologies and businesses, expanding its portfolio and market reach. Its goal is to improve musculoskeletal health by delivering a broad range of surgical solutions for spine and orthopedic care.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Lewisville, Texas

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Top 30 distributors deliver 27% year-over-year growth in Q1 2026.
  • Spine Fixation sales grow 6% from 7D FLASH system momentum.
  • Limb Reconstruction returns to double-digit US growth in H2 2026.

What critics are saying

  • Oxford Finance covenants trigger IP seizure if sales growth falters by 2028.
  • Analysts cut price target to $17.25 amid widened loss forecasts.
  • Spine leadership purge delays 7D FLASH commercialization in 2026.

What makes Orthofix unique

  • Orthofix offers complete internal and external fixation for limb reconstruction.
  • 7D FLASH Navigation System drives spine fixation procedural adoption.
  • FITBONE Trochanteric system targets pediatric patients aged 12-21.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Company News

Yahoo Finance
Apr 9th, 2026
Orthofix restructures spine leadership, reports $196.7M Q1 sales and reaffirms 2026 outlook

Orthofix Medical has restructured its Spine leadership team to accelerate growth and execution, with key leaders now reporting directly to CEO Massimo Calafiore. The company eliminated the President, Global Spine Solutions role, whilst Shaeffer Bannigan assumes expanded responsibilities for Spine strategy and commercial operations. The medical technology company reported preliminary first quarter 2026 net sales of approximately $196.7 million, representing a 0.4% increase on a reported basis and 3% growth on a non-GAAP pro forma constant currency basis compared to Q1 2025. Non-GAAP pro forma net sales, excluding M6 disc sales, totalled approximately $196.4 million. The reorganisation aims to streamline decision-making and strengthen focus on the 7D navigation platform commercialisation. Patrick Fisher has also expanded his remit to include Biologics alongside Limb Reconstruction.

Precedence Research
May 30th, 2025
Xtant Medical Launches OsteoFactor Pro A Groundbreaking Growth Factor Solution to Advance Bone Healing

Xtant Medical launches OsteoFactor Pro A groundbreaking growth factor solution to advance bone healing.

Stock Titan
Mar 12th, 2025
Orthofix Announces Appointment of Vickie Capps to Board of Directors

Orthofix announces Appointment of Vickie Capps to Board of Directors.

PR Newswire
Feb 27th, 2025
The World Brain Mapping Foundation Rises From The Ashes Of The Pacific Palisades Fires To Host The Prestigious Gala And Convention In Los Angeles On The Eve Of The Oscars

LOS ANGELES, Feb. 26, 2025 /PRNewswire/ -- The World Brain Mapping Foundation (WBMF) is set to make a powerful comeback. On March 1st, it will host its 22nd Annual Gathering for the Cure (GFC) award gala at the Millennium Biltmore Hotel in Los Angeles. The red carpet will take place from 6:00 to 8:00 p.m., followed by the award banquet from 8:00 to 11:00 p.m

BioSpace
Feb 18th, 2025
Orthofix To Participate In The Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 9:00 am Pacific TimeLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 9:00 am PT.Interested parties can access the live and archived webcast of the presentation in the “Events & Presentations” section of the Orthofix investor relations website at ir.orthofix.com.Internet Posting of InformationOrthofix routinely posts information that may be important to investors in the “Investors” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.About OrthofixOrthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system

INACTIVE